Description
Product details
Teicocan 200 Injection & Teicocan 400 Injection Generic Name: Teicoplanin for Injection IP Available Strengths: 200 mg & 400 mg Dosage Form: Injection Drug Class: Glycopeptide Antibiotic Teicocan Injection contains Teicoplanin, an injectable glycopeptide antibacterial medicine primarily active against susceptible Gram-positive bacteria. It is generally reserved for serious infections where an injectable Gram-positive antibacterial agent is clinically appropriate. Available Variants Product Composition Strength Teicocan 200 Injection Teicoplanin for Injection IP 200 mg Teicocan 400 Injection Teicoplanin for Injection IP 400 mg Antibacterial Spectrum Teicoplanin has activity against susceptible Gram-positive organisms, which may include: Staphylococcus aureus, including certain methicillin-resistant strains (MRSA) Streptococci Enterococci Other susceptible Gram-positive bacteria Culture and antimicrobial susceptibility testing should guide treatment whenever appropriate. How Teicoplanin Fights Bacteria Teicoplanin interferes with bacterial cell-wall synthesis. By preventing susceptible bacteria from building a functional cell wall, it ultimately causes bacterial cell death. Clinical Applications Depending on approved labeling and susceptibility results, Teicoplanin may be considered for serious infections involving: Skin and soft tissues Bones and joints Bloodstream Heart valves/endocardial infections Other severe Gram-positive bacterial infections Monitoring Focus For patients receiving Teicoplanin, particularly during prolonged therapy, clinicians may consider monitoring: Kidney Function → Blood Counts → Liver Function → Hearing → Clinical Response Therapeutic drug monitoring may also be appropriate in certain patients or treatment situations. Important Safety Points Extra caution is required in patients with: Kidney impairment Previous glycopeptide hypersensitivity Hearing impairment Concurrent nephrotoxic or ototoxic medicines Renal impairment can alter Teicoplanin elimination, so dose adjustment or interval modification may be required. Possible Adverse Effects Potential reactions include: Injection-site discomfort Rash or itching Fever Nausea Changes in liver enzymes Blood-cell abnormalities
